DNAS cited in Science Advances

DNAS cited in Science Advances

Early identification of pathogens is essential for limiting development of therapy-resistant pathogens and mitigating infectious disease outbreaks. Most bacterial detection schemes use target-specific probes to differentiate pathogen species, creating time and cost inefficiencies in identifying Read more ›

Antisense Webinar Transcript

Better Antisense Design Without the Trial and Error:  Problems we Solve

Most researchers use naïve strategies to design antisense oligonucleotides.  However, to maximize assay sensitivity and specificity one must consider probe and target sequence and their respective and combined chemistries.  Read more ›

The Real Cost of Multiplex

Real Cost of Multiplex

This conversation is consistent with our feedback from customers throughout the years.   Building a successful multiplex is hard, expensive and time-consuming.  Often times we work with customers after they’ve already tried “going it alone”.  We unfortunately Read more ›

DNA Software partnership with Insilixa

InSilixa Inc. and DNA Software Inc. enter into agreement to develop state-of-the-art high-multiplex infectious disease panels for commercialization on InSilixa’s CMOS biochip platform

See press coverage at Genome Web

dna software partners with insilixia

Infectious disease molecular diagnostic (MDx) assays developed in partnership with inSilixa Read more ›